OS Therapies, Inc. (OSTX)
1.00
+0.02
(+2.03%)
USD |
NYAM |
Nov 06, 16:00
0.9355
-0.06
(-6.45%)
After-Hours: 20:00
OS Therapies Total Liabilities (Quarterly) : 20.64M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 20.64M |
| March 31, 2026 | 16.95M |
| December 31, 2025 | 11.76M |
| September 30, 2025 | 4.145M |
| June 30, 2025 | 3.458M |
| March 31, 2025 | 3.536M |
| December 31, 2024 | 10.68M |
| September 30, 2024 | 2.584M |
| June 30, 2024 | 28.31M |
| March 31, 2024 | 26.46M |
| Date | Value |
|---|---|
| December 31, 2023 | 24.71M |
| September 30, 2023 | 23.07M |
| June 30, 2023 | |
| March 31, 2023 | 19.59M |
| December 31, 2022 | 17.97M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 10.87B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 406.66M |
| Alnylam Pharmaceuticals, Inc. | 4.391B |
| Anika Therapeutics, Inc. | 52.02M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.94M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.897M |
| Shareholders Equity (Quarterly) | -10.84M |
| Current Ratio | 0.1764 |